Page last updated: 2024-10-16

aminolevulinic acid and Mycosis Fungoides

aminolevulinic acid has been researched along with Mycosis Fungoides in 25 studies

Aminolevulinic Acid: A compound produced from succinyl-CoA and GLYCINE as an intermediate in heme synthesis. It is used as a PHOTOCHEMOTHERAPY for actinic KERATOSIS.
5-aminolevulinic acid : The simplest delta-amino acid in which the hydrogens at the gamma position are replaced by an oxo group. It is metabolised to protoporphyrin IX, a photoactive compound which accumulates in the skin. Used (in the form of the hydrochloride salt)in combination with blue light illumination for the treatment of minimally to moderately thick actinic keratosis of the face or scalp.

Mycosis Fungoides: A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.

Research Excerpts

ExcerptRelevanceReference
"We present the kinetics of ALA-induced protoporphyrin IX (PP) accumulation and the results of ALA PDT treatment on two patients with different stages (stage I and stage III) of mycosis fungoides (MF)-type cutaneous T-cell lymphoma (CTCL)."3.70Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application. ( Haik, J; Kostenich, G; Malik, Z; Orenstein, A; Tamir, J; Trau, H; Winkler, E, 2000)
"Plaque-phase mycosis fungoides is among the most promising possibilities for the use of this treatment."2.75[Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients]. ( De Las Heras, E; Fernández-Guarino, M; Harto, A; Jaén, P; Montull, C; Pérez-García, B, 2010)
"Selection of appropriate treatment for mycosis fungoides (MF) is based on prognostic factors and overall clinical stage at diagnosis."2.58Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis. ( Cazzaniga, S; Hunger, RE; Seyed Jafari, SM, 2018)
"Mycosis fungoides is the most common cutaneous T cell lymphoma."2.58Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis. ( Cazzaniga, S; Hunger, RE; Seyed Jafari, SM, 2018)
"Mycosis fungoides is the most common cutaneous T-cell lymphoma."2.55Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review. ( Liu, C; Liu, Y; Xue, J, 2017)
"Mycosis fungoides is the most common type of cutaneous T-cell lymphoma."1.38Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides. ( Baek, JW; Jeon, YS; Kang, DY; Kang, JS; Kim, ST; Suh, KS, 2012)

Research

Studies (25)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (8.00)18.2507
2000's8 (32.00)29.6817
2010's13 (52.00)24.3611
2020's2 (8.00)2.80

Authors

AuthorsStudies
Severson, KJ1
Cumsky, HJL1
Brumfiel, CM1
Janeczek, MC1
Ginos, BF1
Kosiorek, HE1
Besch-Stokes, J1
Patel, MH1
Rule, WG1
DiCaudo, DJ1
Rosenthal, AC1
Pittelkow, MR1
Mangold, AR1
Juan-Carpena, G1
Palazón-Cabanes, JC1
Blanes-Martínez, M1
Teixeira, AI1
Maia E Silva, J1
Pileri, A1
Sgubbi, P1
Agostinelli, C1
Infusino, SD1
Vaccari, S1
Patrizi, A1
Seyed Jafari, SM1
Cazzaniga, S1
Hunger, RE1
Quéreux, G1
Brocard, A1
Saint-Jean, M1
Peuvrel, L1
Knol, AC1
Allix, R1
Khammari, A1
Renaut, JJ1
Dréno, B1
Hasson, A1
Navarrete-Dechent, C1
Nicklas, C1
Sazunic, I1
Bosseila, M1
Mahgoub, D1
El-Sayed, A1
Salama, D1
Abd El-Moneim, M1
Al-Helf, F1
Han, D1
Xue, J2
Wang, T1
Liu, Y2
Liu, C1
Hegyi, J2
Frey, T2
Arenberger, P2
Debu, A2
Girard, C2
Kluger, N1
Guillot, B2
Dereure, O2
Fernández-Guarino, M1
Harto, A1
Pérez-García, B1
Montull, C1
De Las Heras, E1
Jaén, P2
Kim, ST1
Kang, DY1
Kang, JS1
Baek, JW1
Jeon, YS1
Suh, KS1
Bessis, D1
Du Thanh, A1
Paech, V1
Lorenzen, T1
Stoehr, A1
Lange, K1
Merz, H1
Meigel, WN1
Plettenberg, A1
Yokoyama, S1
Nakano, H1
Nishizawa, A1
Kaneko, T1
Harada, K1
Hanada, K1
Recio, ED1
Zambrano, B1
Alonso, ML1
de Eusebio, E1
Martín, M1
Cuevas, J1
Edström, DW1
Hedblad, MA1
Ammann, R1
Hunziker, T1
Wolf, P1
Fink-Puches, R1
Cerroni, L1
Kerl, H1
Orenstein, A1
Haik, J1
Tamir, J1
Winkler, E1
Trau, H1
Malik, Z1
Kostenich, G1
Markham, T1
Sheahan, K1
Collins, P1
Kabata, Y1
Shimomura, Y1
Matsuo, Y1
Fujiwara, H1
Abe, R1

Reviews

4 reviews available for aminolevulinic acid and Mycosis Fungoides

ArticleYear
Photodynamic therapy as an alternative treatment for mycosis fungoides: a systemic review and meta-analysis.
    Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018, Volume: 153, Issue:6

    Topics: Aminolevulinic Acid; Humans; Mycosis Fungoides; Neoplasm Staging; Photochemotherapy; Photosensitizin

2018
Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: a prospective open study and review of the literature.
    Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:6

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Mycosis Fungoides;

2013
Photodynamic therapy as an alternative treatment for relapsed or refractory mycosis fungoides: A systemic review.
    Photodiagnosis and photodynamic therapy, 2017, Volume: 17

    Topics: Aminolevulinic Acid; Humans; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agents; Skin Neo

2017
Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
    International journal of dermatology, 2008, Volume: 47, Issue:4

    Topics: Administration, Topical; Adult; Aminolevulinic Acid; Female; Humans; Low-Level Light Therapy; Male;

2008

Trials

2 trials available for aminolevulinic acid and Mycosis Fungoides

ArticleYear
Does fluorescence diagnosis have a role in follow up of response to therapy in mycosis fungoides?
    Photodiagnosis and photodynamic therapy, 2014, Volume: 11, Issue:4

    Topics: Adolescent; Adult; Aged; Aminolevulinic Acid; Contrast Media; Dermoscopy; Female; Follow-Up Studies;

2014
[Plaque-phase mycosis fungoides treated with photodynamic therapy: results from 12 patients].
    Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:9

    Topics: Adrenal Cortex Hormones; Adult; Aminolevulinic Acid; Combined Modality Therapy; Female; Fluorescence

2010

Other Studies

19 other studies available for aminolevulinic acid and Mycosis Fungoides

ArticleYear
Blue light photodynamic therapy with 5-aminolevulinic acid in refractory mycosis fungoides: A prospective, open-label study.
    Journal of the American Academy of Dermatology, 2021, Volume: 85, Issue:4

    Topics: Aminolevulinic Acid; Humans; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agents; Prospect

2021
Successful treatment of palmoplantar dyshidrotic lesions of mycosis fungoides with conventional and daylight photodynamic therapy.
    Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2021, Volume: 19, Issue:7

    Topics: Aminolevulinic Acid; Humans; Mycosis Fungoides; Photochemotherapy; Skin Neoplasms

2021
Terapêutica Fotodinâmica com metil-aminolevulinato no tratamento de lesões refractárias de Micose Fungóide: resposta clínica e histológica mantida em dois doentes.
    Dermatology online journal, 2016, Sep-15, Volume: 22, Issue:9

    Topics: Administration, Cutaneous; Adrenal Cortex Hormones; Aged; Aminolevulinic Acid; Humans; Male; Mycosis

2016
Photodynamic therapy: An option in mycosis fungoides.
    Photodiagnosis and photodynamic therapy, 2017, Volume: 20

    Topics: Adult; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Photochemotherapy;

2017
Topical photodynamic therapy with 5-aminolevulinate for the treatment of tumor-stage mycosis fungoides: a case report.
    International journal of dermatology, 2013, Volume: 52, Issue:12

    Topics: Aged; Aminolevulinic Acid; Humans; Male; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agen

2013
Observation of clinical efficacy of photodynamic therapy in 3 patients with refractory plaque-stage mycosis fungoides.
    Photodiagnosis and photodynamic therapy, 2016, Volume: 16

    Topics: Administration, Cutaneous; Adult; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Mycosis Fu

2016
Unilesional mycosis fungoides treated with photodynamic therapy. A case report.
    Acta dermatovenerologica Alpina, Pannonica, et Adriatica, 2008, Volume: 17, Issue:2

    Topics: Aged; Aminolevulinic Acid; Humans; Male; Mycosis Fungoides; Photochemotherapy; Skin Neoplasms

2008
Topical methyl aminolaevulinate-photodynamic therapy in erosive facial mycosis fungoides.
    The British journal of dermatology, 2010, Volume: 163, Issue:4

    Topics: Aged, 80 and over; Aminolevulinic Acid; Facial Neoplasms; Humans; Male; Mycosis Fungoides; Photochem

2010
Photodynamic therapy with methyl-aminolaevulinic acid for mycosis fungoides.
    Acta dermato-venereologica, 2012, Volume: 92, Issue:3

    Topics: Adult; Aged; Aminolevulinic Acid; Female; Humans; Male; Middle Aged; Mycosis Fungoides; Occlusive Dr

2012
Photodynamic therapy with methyl aminolaevulinate for cervical and/or facial lesions of folliculotropic mycosis fungoides: interest and limits.
    The British journal of dermatology, 2013, Volume: 168, Issue:4

    Topics: Aged; Aminolevulinic Acid; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Mycosis Fungo

2013
Remission of a cutaneous Mycosis fungoides after topical 5-ALA sensitisation and photodynamic therapy in a patient with advanced HIV-infection.
    European journal of medical research, 2002, Nov-25, Volume: 7, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Aminolevulinic Acid; Humans; Male; Middle Aged; Mycosis Fungoide

2002
A case of photocontact urticaria induced by photodynamic therapy with topical 5-aminolaevulinic acid.
    The Journal of dermatology, 2005, Volume: 32, Issue:10

    Topics: Administration, Topical; Aged; Aminolevulinic Acid; Female; Humans; Mycosis Fungoides; Photochemothe

2005
The treatment of unilesional mycosis fungoides with methyl aminolevulinate-photodynamic therapy.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2008, Volume: 22, Issue:9

    Topics: Aged; Aminolevulinic Acid; Humans; Male; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agen

2008
Long-term follow-up of photodynamic therapy for mycosis fungoides.
    Acta dermato-venereologica, 2008, Volume: 88, Issue:3

    Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Humans; Male; Middle Aged;

2008
Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
    Journal of the American Academy of Dermatology, 1995, Volume: 33, Issue:3

    Topics: Administration, Cutaneous; Aminolevulinic Acid; Humans; Mycosis Fungoides; Photochemotherapy; Remiss

1995
Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid.
    Journal of the American Academy of Dermatology, 1994, Volume: 31, Issue:4

    Topics: Administration, Cutaneous; Adult; Aged; Aminolevulinic Acid; Female; Humans; Mycosis Fungoides; Phot

1994
Photodynamic therapy of cutaneous lymphoma using 5-aminolevulinic acid topical application.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2000, Volume: 26, Issue:8

    Topics: Abdomen; Administration, Topical; Adult; Aged; Aminolevulinic Acid; Facial Dermatoses; Humans; Lymph

2000
Topical 5-aminolaevulinic acid photodynamic therapy for tumour-stage mycosis fungoides.
    The British journal of dermatology, 2001, Volume: 144, Issue:6

    Topics: Aged; Aminolevulinic Acid; Humans; Male; Mycosis Fungoides; Photochemotherapy; Photosensitizing Agen

2001
Photodynamic therapy with intradermal application of 5-aminolevulinic acid successfully improved tumor lesions of mycosis fungoides.
    International journal of dermatology, 2017, Volume: 56, Issue:4

    Topics: Aged, 80 and over; Aminolevulinic Acid; Female; Humans; Injections, Intralesional; Levulinic Acids;

2017